Dravet Syndrome (DS)

Dravet Syndrome (DS) is the indication for 4 drugs in DrugBank. It is covered by 5 curated, structured indications.

Also known as: Dravet Syndrome
Classified under: Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Nervous System Diseases
Signs and Symptoms
Indicated drugs: Cannabidiol
Clobazam
Fenfluramine
Stiripentol

Resolves to

Vocabularies

MeSHT812423ICD-10G40.83SNOMED CT230437002MedDRA10073677UMLSC0751122

What you can answer from here — as of November 14, 2026

4Indicated drugsWith each drug's targets and mechanism

Listed above

5Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

55Clinical trialsPhase, status and sponsor resolved per trial

2Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Dravet Syndrome (DS) share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.